A High Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury during the COVID-19 pandemic
Maria Alimova, Eriene-Heidi Sidhom, Abhigyan Satyam, et al.
AND
Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses
Willianne Hoepel, Hung-Jen Chen, Sona Allahverdiyeva, et al.
Selected by
Yen-Chung Chen
